ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

SHP Shire

4,690.00
0.00 (0.00%)
18 Apr 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Shire LSE:SHP London Ordinary Share JE00B2QKY057 ORD 5P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 4,690.00 0.00 01:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
0 0 N/A 0

Shire plc Shire Plc : Additional Listing

06/07/2017 7:30am

Dow Jones News


Shire (LSE:SHP)
Historical Stock Chart


From Apr 2019 to Apr 2024

Click Here for more Shire Charts.
TIDMSHP 
 
 
   Additional Listing 
 
   July 6, 2017 - Shire plc (LSE: SHP, NASDAQ: SHPG) (the "Company") hereby 
notifies the market that an application has been made to the London 
Stock Exchange and the UK Listing Authority for a total of 3,000,000 
Ordinary Shares of 5 pence each fully paid (the "Shares") to trade on 
the London Stock Exchange and to be admitted to the Official List. The 
Shares are to be reserved under a block listing pursuant to the Shire 
Portfolio Share Plan, the Shire Long Term Incentive Plan 2015 and the 
Shire Global Employee Stock Purchase Plan. 
 
   When issued, the Shares will rank equally with the existing issued 
Ordinary Shares of the Company. 
 
   Oliver Strawbridge 
 
   Senior Assistant Company Secretary 
 
   For further information please contact: 
 
 
 
 
Investor Relations 
Ian Karp             ikarp@shire.com        +1 781 482 9018 
Robert Coates        rcoates@shire.com      +44 1256 894874 
Media 
Lisa Adler           lisa.adler@shire.com   +1 617 588 8607 
Debbi Ford           debbi.ford@shire.com   +1 617 949 9083 
 
 
   NOTES TO EDITORS 
 
   About Shire 
 
   Shire is the leading global biotechnology company focused on serving 
people with rare diseases. We strive to develop best-in-class products, 
many of which are available in more than 100 countries, across core 
therapeutic areas including Hematology, Immunology, Neuroscience, 
Ophthalmics, Lysosomal Storage Disorders, Gastrointestinal / Internal 
Medicine / Endocrine and Hereditary Angioedema; and a growing franchise 
in Oncology. 
 
   Our employees come to work every day with a shared mission: to develop 
and deliver breakthrough therapies for the hundreds of millions of 
people in the world affected by rare diseases and other high-need 
conditions, and who lack effective therapies to live their lives to the 
fullest. 
 
   www.shire.com 
 
   This announcement is distributed by Nasdaq Corporate Solutions on behalf 
of Nasdaq Corporate Solutions clients. 
 
   The issuer of this announcement warrants that they are solely 
responsible for the content, accuracy and originality of the information 
contained therein. 
 
   Source: Shire plc via Globenewswire 
 
 
 
 

(END) Dow Jones Newswires

July 06, 2017 02:15 ET (06:15 GMT)

Copyright (c) 2017 Dow Jones & Company, Inc.

1 Year Shire Chart

1 Year Shire Chart

1 Month Shire Chart

1 Month Shire Chart

Your Recent History

Delayed Upgrade Clock